InterSystems to ramp up China input

US data tech company mulls forays into more fields for higher growth

InterSystems Corp, a US-based data technology company, will ramp up efforts to expand investments in China, accelerate the digital transformation of the healthcare industry and make forays into more fields like pharmaceutical, big data and fintech, said a senior executive of the company.

Luciano Brustia, regional managing director of the Asia Pacific at Inter-Systems, said the Chinese market is of great significance in the company's global business layout and has become one of the fast-growing markets across the globe, adding that he is bullish on the prospects of China's huge growth potential.

Brustia said the company's business in China grew by around 8 percent year-on-year in 2022 despite the challenges brought by the COVID-19 pandemic, and the growth momentum is expected to be maintained this year. Brustia said he is very glad to see that China's economy has been recovering with stronger impetus and he has full confidence in the country's future economic growth.